电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant TNFRSF9 (Urelumab Biosimilar) 抗体

The Human 单克隆 anti-TNFRSF9 (Urelumab Biosimilar) antibody (ABIN7675691) specifically detects TNFRSF9 (Urelumab Biosimilar) in ELISA, BLI, FACS, Func 和 SPR. The antibody is reactive with 人 samples.
产品编号 ABIN7675691
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant TNFRSF9 (Urelumab Biosimilar) 抗体 (ABIN7675691)

抗原

TNFRSF9 (Urelumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 2
  • 1
  • 1
Human

克隆类型

  • 4
单克隆

标记

  • 3
  • 1
This TNFRSF9 (Urelumab Biosimilar) antibody is un-conjugated

应用范围

ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    原理

    Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab)

    序列

    QVQLQQWGAG LLKPSETLSL TCAVYGGSFS GYYWSWIRQS PEKGLEWIGE INHGGYVTYN PSLESRVTIS VDTSKNQFSL KLSSVTAADT AVYYCARDYG PGNYDWYFDL WGRGTLVTVS SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTK TYTCNVDHKP SNTKVDKRVE SKYGPPCPPC PAPEFLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSQE DPEVQFNWYV DGVEVHNAKT KPREEQFNST YRVVSVLTVL HQDWLNGKEY KCKVSNKGLP SSIEKTISKA KGQPREPQVY TLPPSQEEMT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSR LTVDKSRWQE GNVFSCSVMH EALHNHYTQK SLSLSLGK,EIVLTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYD ASNRATGIPA RFSGSGSGTD FTLTISSLEP EDFAVYYCQQ RSNWPPALTF CGGTKVEIKR TVAAPSVFIF PPSDEQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN SQESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC

    产品特性

    Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 146.5 kDa.

    纯度

    >95 %

    亚型

    IgG4 S228P
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    Therapeutic Agents by Target and Mechanism: 4-1BB agonist

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    TNFRSF9 (Urelumab Biosimilar)

    物质类

    Biosimilar

    分子量

    146.5 kDa

    UniProt

    Q07011
You are here: